Arcus Biosciences Inc (RCUS)

04:17 AM

Using AI based signals to follow Arcus Biosciences Inc.Weekly Volume Report & Entry Point Confirmation Signals - newser.com

04:17 AM

03:56 AM

Analyzing recovery setups for Arcus Biosciences Inc. investors2025 Valuation Update & Advanced Technical Analysis Signals - newser.com

03:56 AM

07:37 AM

Arcus Biosciences Inc. recovery potential after sell offMarket Performance Recap & Long-Term Safe Return Strategies - newser.com

07:37 AM

03:55 AM

Why Arcus Biosciences Inc. stock appears on watchlistsTrade Entry Report & Consistent Profit Alerts - newser.com

03:55 AM

02:28 AM

Is Arcus Biosciences Inc. stock safe for risk averse investorsQuarterly Market Review & Fast Gaining Stock Reports - newser.com

02:28 AM

Oct 20, 2025

Should you hold or exit Arcus Biosciences Inc. nowEarnings Overview Report & Technical Pattern Based Signals - newser.com

Oct 20, 2025

Oct 20, 2025

Is this a good reentry point in Arcus Biosciences Inc.July 2025 Highlights & Entry Point Confirmation Signals - newser.com

Oct 20, 2025

Oct 20, 2025

How moving averages guide Arcus Biosciences Inc. tradingJuly 2025 WrapUp & Daily Volume Surge Signals - newser.com

Oct 20, 2025

Oct 20, 2025

RCUS: Wells Fargo Raises Price Target on Arcus Biosciences to $2 - GuruFocus

Oct 20, 2025

Oct 20, 2025

Published on: 2025-10-20 09:03:52 - newser.com

Oct 20, 2025

Oct 20, 2025

Applying sector rotation models to Arcus Biosciences Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com

Oct 20, 2025

Oct 20, 2025

Published on: 2025-10-20 00:14:27 - newser.com

Oct 20, 2025

Oct 19, 2025

Taiho Exercises Option for Casdatifan Development with Arcus (RC - GuruFocus

Oct 19, 2025

Oct 19, 2025

Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com

Oct 19, 2025

Oct 19, 2025

Exclusive license for casdatifan in Japan & select Asian territories — Taiho exercises option from Arcus - Stock Titan

Oct 19, 2025

Oct 19, 2025

Arcus Biosciences Hits Day High with Strong 8.19% Intraday Surge - Markets Mojo

Oct 19, 2025

Oct 19, 2025

Arcus Biosciences Hits Day High with 13.97% Surge Amid Market Decline - Markets Mojo

Oct 19, 2025

Oct 19, 2025

What analysts say about Arcus Biosciences Inc stockGlobal Trade Effects & Fast Growing Trading Plans - earlytimes.in

Oct 19, 2025

Oct 19, 2025

Visual analytics tools that track Arcus Biosciences Inc. performanceWeekly Risk Report & Verified Entry Point Signals - newser.com

Oct 19, 2025

Oct 19, 2025

Will Arcus Biosciences Inc. outperform the marketEarnings Growth Summary & Entry Point Strategy Guides - newser.com

Oct 19, 2025

Oct 18, 2025

Movement Recap: Will Arcus Biosciences Inc. stock benefit from sector rotation2025 Buyback Activity & AI Forecast Swing Trade Picks - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

Can momentum traders help lift Arcus Biosciences Inc.Portfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Oct 18, 2025

Oct 18, 2025

Why Arcus Biosciences Inc. stock is rated strong buyQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com

Oct 18, 2025

Oct 18, 2025

Growth Recap: Will Arcus Biosciences Inc. stock benefit from sector rotationJuly 2025 Institutional & Risk Managed Investment Entry Signals - nchmf.gov.vn

Oct 18, 2025

Oct 17, 2025

Can Arcus Biosciences Inc. stock deliver consistent EPS growthJuly 2025 Earnings & Fast Gaining Stock Reports - nchmf.gov.vn

Oct 17, 2025

Oct 16, 2025

Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge Markets - Seeking Alpha

Oct 16, 2025

Oct 15, 2025

Arcus data throw TIGIT a lifeline: Clinical Report - biocentury.com

Oct 15, 2025

Oct 15, 2025

What dividend safety score for Arcus Biosciences Inc. stockMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Arcus Biosciences reports Phase 2 survival data for gastric cancer study - Investing.com Australia

Oct 15, 2025

Oct 14, 2025

Arcus’s ‘Last TIGIT Standing’ Shows Phase II Survival Benefit - Citeline News & Insights

Oct 14, 2025

Oct 14, 2025

Arcus Biosciences Reports Promising Phase 2 Study Results - TipRanks

Oct 14, 2025

Oct 14, 2025

Arcus Biosciences reports Phase 2 survival data for gastric cancer study By Investing.com - Investing.com South Africa

Oct 14, 2025